Abstract
Before the turn of the century, insulin-independent diabetes mellitus (IDDM) was shown to develop in pancreatectomized dogs (1), thus linking the pathogenesis of the syndrome to the pancreas. Later, insulin was extracted from the pancreas and proved to ameliorate most of the diabetic symptoms(2). However, it became clear that insulin was not a cure. In 1965, Gepts reported (3), that the major morphologic alteration in the pancreas at the onset of IDDM was disruption of the architecture of the islets of Langerhans and a loss of cells. The number of B cells was reduced to less than 10% of normal values and in 68% of the pancreata examined, the islets were infiltrated by mononuclear cells. Islet inflammation, insulitis, is therefore thought to be of pathogenetic importance (3–6). Infiltration of the islets of Langerhans has also been associated with experimental diabetes introduced by immunization with insulin (7–8), by multiple injections of low dose streptozotocin (9) or following infection with diabetogenic viruses (10,11).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Mering J von, Minkowski O: Diabetes Mellitus nach Pankreasextirpation: Arch. Exp. Pathol. Pharmakol. 26: 371–387, 1889.
Banting FG, Best CB, Collip JB, Cambell WR, Fletcher AA: Pancreatic extract in the treatment of diabetes mellitus: Canad. Med. Ass. J. 2: 141–146, 1922.
Gepts W: Pathologic anatomy of the pancreas in juvenile diabetes mellitus: Diabetes 14: 619–633, 1965.
Foulis AK, Stewart JA: The pancreas in recent-onset Type 1 (insulin-dependent) diabetes mellitus: insulin content of islets, insulitis and associated changes in the exocrine acinar tissue: Diabetologia 26: 456–461, 1984.
Bottazzo GF, Dean BM, McNally JM, McKay EH, Swift PGF, Gamble DR: In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis: New Engl. J. Med. 313: 353–360, 1985.
Rahier J, Goebbels RM, Henquin JC: Cellular composition of the human diabetic pancreas: Diabetologia 24: 366–371, 1983.
Lacy PE, Wright PH, Silverman JL: Eosinophilic infiltration in the pancreas of rats injected with anti-insulin serum: Fed. Proc. 22: 60, 1963.
Renold AE, Soeldner JS, Steincke J: Immunologic studies with homologous and heterologous pancreatic insulin in the cow: Ciba Foundations Colloquia 15: 122, 1964.
Like AA, Rossine AA: Streptozotocin - induced pancreatic insulitis: new model of diabetes mellitus: Science 193: 415–417, 1976.
Craighead JE: The role of viruses in the pathogenesis of pancreatic disease and diabetes mellitus: Prog. Med. Virol. 19: 161–214, 1975.
Notkins AL: Virus-induced diabetes mellitus: Brief review: Arch. Virol. 54: 1–17, 1977.
Nerup J, Andersen OO, Bendixen G, Egeberg J, Poulsen JE: Anti-pancreatic, cellular hypersensitivity in diabetes mellitus. Antigenic activity of fetal calf pancreas and correlation with clinical type of diabetes: Acta Allergol 28: 223–230, 1973.
Bottazzo GF, Florin-Christensen A, Doniach D: Islet cell antibodies in diabetes mellitus with autoimmune polyendocrine defiencies: Lancet ii: 1279–1283, 1974.
Lernmark Å, Freedman ZR, Hofmann C, Rubenstein AH, Steiner DF, Jackson RL, Winter RJ, Traisman HS: Islet cell surface antibodies in juvenile diabetes mellitus: N. Engl. J. Med. 299: 375–380, 1978.
Platz P, Jackson BK, Morling M, Ryder LP, Svejgaard A, Thomsen M, Christy M, Kromann H, Benn J, Nerup J, Green A, Hauge M: HLA-D and DR-antigens in genetic analysis of insulin-dependent diabetes mellitus: Diabetologia 21: 100–115, 1981.
Barbosa J, Chavers B, Dunsworth T, Michael A: Islet cell antibodies and histocompatibility antigens (HLA) in insulin-dependent diabetes and their first degree relatives: Diabetes 31: 585–588, 1982.
Owerbach D, Lernmark Å, Platz P, Ryder LP, Rask L, Peterson PA, Ludvigson J: HLA-D region 3-chain DNA endonuclease fragments differ between HLA-DR identical healthy and insulin-dependent diabetic individuals: Nature 303: 815–817, 1983.
Andreani D, DiMario U, Federlin KF, Heding LG (eds): Immunulogy in Diabetes: Kimpton Medical Publications, London, 1984.
Todd I, Bottazzo GF: Laboratory investigation of autoimmune endocrine diseases: Clinics in Immunol, and Allergy 5: 613–638, 1985.
Rossini AA, Mordes JP, Like AA: Immunology of insulin-dependent diabetes mellitus: Ann. Rev. Immunol. 3: 289–320, 1985.
Honjo T: Origin of immune diversity: genetic variation and selection: Ann. Rev. Biochem. 54: 803–830, 1985.
Jerne NK: Towards a network theory of the immune system: Ann. Immunal. (Paris) 125: 373–382, 1974.
Wasserman NH, Penn AS, Freimuth PI, Treptow N, Wentzel S, Cleveland WL and Erlanger BF: Anti-idiotypic route to anti-acetylcholine receptor antibodies and experimental myasthenia gravis: Proc. Natl. Acad. Sci. USA 79: 4810–4816, 1982.
McConnell I, Munro A, Waldmann H: Autoimmune Disease in the immune system — a course on the molecular and cellular basis of immunity, 2nd ED: Blackwell Scientific Publ. London, p. 273, 1981.
Ayoub EM, Barret DJ, MacLaren NK, Krischer JP: Association of Class II Human Histocompatibility Leykocyte antigens with rheumatic fever: J. Clin. Invest. 77: 2019–2026, 1986.
Weiss M, Ingbar SH, Winblad S, Kaspar DL: Demonstration of a saturable binding site for thyrotropin in Yersinia enterocolitica: Science 219: 1331–1333, 1983.
Waldmann TA, Broder S: Polyclonal B-cell activators in the study of the regulation of immunoglobulin synthesis in the human system: Adv. Immunol. 48: 196–200, 1982.
Walls KW, Smith JW: Serology of parasite infections: Int. J. Parasitol. 10: 329–340, 1979.
Perrin LH, Mackey LJ, Lambert PH: Immunology of malaria: In: Clinical Immunal. Update (Rosse WF, ed) Elsevier, N.Y. pp. 234–264, 1985.
Owerbach D, Lernmark Å, Rask L, Peterson PA, Platz P, Svejgaard A: Detection of HLA-D/DR-related DNA polymorphism in HLA-D homozygous typing cells: Proc. Natl. Acad. Sci. USA 80: 3758–3761, 1983.
Owerbach D, Hägglöff B, Lernmark Å, Holmgren G: Susceptibility to insulin-dependent diabetes defined by restriction enzyme polymorphism of HLA-D region genomic DNA: Diabetes 33: 958–965, 1984.
Cohen-Haguenauer O, Robbins E, Massart C, Busson M, Deschamps I, Hors J, Lalouel JM, Dausset J, Cohen D: A systematic study of HLA class II-β DNA restriction fragments in insulin-dependent diabetes mellitus: Proc. Natl. Acad. Sci. USA, 82: 3335–3339, 1985.
Böhme J, Carlsson B, Wallin J, Möller E, Persson B, Peterson PA, Rask L: Only one of each DR specificity is associated with insulin-dependent diabetes: J. Immunol. 137: 941–947, 1986.
Michelsen B, Kastern W, Lernmark Å, Owerbach D: Identification of an HLA-DC β-chain related genomic sequence associated with insulin-dependent diabetes: Biomed. Biochim. Acta 44, 1: 33–36, 1985.
Michelsen B, Lernmark Å: HLA-DQ gene polymorphism in insulin-dependent diabetes: Proc. of the Satelite Symposium Immunology in Diabetes, Edmonton, in press, 1986.
Boss JM, Stromminger JL: Cloning and sequence analysis of the human major histocompatibility complex gene DC-33: Proc. Natl. Acad. Sci. USA. 81: 5199–5203, 1985.
Rotter JI, Rimoin DL: The genetics of the glucose intolerance disorders: Am. J. Med. 70: 116–126, 1981.
Barnett AH, Eff C, Leslie RDG, Pyke DA: Diabetes in identical twins: a study of 200 pairs: Diabetologia 20: 87–93, 1981.
Dahlquist G, Blom L, Holmgren G, Hägglöff B, Larson Y, Sterky G, Wall S: The epidemiology of diabetes in Swedish Children 0–14 years — A six-year prospective study. Diabetologia 28: 802–808, 1985.
Nakhooda AF, Like AA, Chappel CI, Murray FT, Marliss EB: The spontaneously diabetic Wistar rat. Metabolic and morphologic studies: Diabetes 26: 100–112, 1977.
The juvenile Diabetes Foundation workshop on the spontaneously diabetic BB rat: Its potential for insight into human juvenile diabetes: Marliss EB (ed): Metabolism, 32 suppl 1: 1–166, 1983.
Ono SJ, Colle E, Guttmann RD, Fuks A: MHC association of IDDM in the BB rat maps to permissive immune response genes. In “Immunology of diabetes”, Molnar GD, Jaworski MA, eds: Elsevier publ., New York, (in press), 1986.
Jackson RA, Buse JB, Rifai R, Pelletier D, Milford EL, Carpenter CB, Eisenbarth GS: Diabetes in BB rats: J. Exp. Med. 159: 1629–1636, 1984.
Kastern W, Dyrberg T, Schöller J, Kryspin-Sørensen I: Restriction fragment polymorphisms in the major histocompatibility complex of diabetic BB rats: Diabetes 33: 807–809, 1984.
Björck L, Kryspin-Sørensen I, Dyrberg T, Lernmark Å, Kastern W:A deletion in a rat major histocompatibility complex class I gene is linked to the absence of β2-microglobulin — containing serum molecules: Proc. Natl. Acad. Sci. USA (in press), 1986.
Christau B, Kromann H, Ortved Andersen O, Christy M, Bushard K, Armung K: Seasonal and geographical patterns of juvenile-onset insulin-dependent diabetes in Denmark: Diabetologia 13: 281–284, 1977.
Weringer EJ, Like AA: Immune attack on pancreatic islet transplant in the spontaneously diabetic Biobreeding/Worcester (BB/W) rat is not MHC restricted: J. Immunol. 134: 2383–2386, 1985.
Bækkeskov S, Dyrberg T, Lernmark Å: Autoantibodies against a Mr 64000 islet cellprotein precede the onset of spontaneous diabetes: Science 224: 1348–1350, 1984.
Bækkeskov S, Nielsen JH, Marner B, Bilde T, Ludvigson J, Lernmark Å: Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell proteins: Nature 298: 167–169, 1982.
Bækkeskov S, Bruining S, Srikanta T, Mandrup-Poulsen T, Beaufort C, Eisenbarth GS, Lernmark Å: Antibodies to a M 64000 human islet cell protein in the prediabetic period of IDDM patients: Ann. N.Y. Acad. Sci. 475: 415–417, 1986.
Kanatsuna T, Bækkeskov S, Lernmark Å, Ludvigson J: Immunoglobulin from insulin-dependent diabetic children inhibits glucose-induced insulin release: Diabetes 32: 520–524, 1983.
Bækkeskov S, Kanatsuna T, Klareskog L, Nielsen DA, Peterson PA, Rubenstein AH, Steiner DF, Lernmark Å: Expression of major histocompatibility antigens on pancreatic islet cells: Proc. Natl. Acad. Sci. USA 78: 6456–6460, 1981.
Faustman D, Hauptfeld V, Davie JM, Lacy PE, Schreffler DC: Murine pancreatic-cells express H-2K and H-2D but not Ia antigens: J. Exp. Med. 151: 1563–1568, 1980.
Dean BM, Walker R, Bone AJ, Baird JD, Cooke A: Pre-diabetes in the spontaneously diabetic BB/E rat: lymphocyte subpopulations in the pancreatic infiltrate and expression of MHC class II molecules in endocrine cells: Diabetologia 28: 464–466, 1985.
Agger R, Petersen J, Dinesen B, Wiik A, Andersen A: Production and secretion of immunolobulins by in vitro activated lymphocytes: Allergy 37: 179–185, 1982.
Horita M, Suzuki H, Onodera T, Ginsberg-Fellner F, Fanci AS, Notkins AL: Abnormalities of immunoregulatory T cell subsets in patients with insulin-dependent diabetes mellitus: J. Immunol 129: 1426–1429, 1982.
Papadopoulos G, Petersen J, Andersen V, Lernmark Å, Marner B, Nerup J, Binder C: Spontaneous in vitro immunoglobulin secretion at the diagnosis of insulin-dependent diabetes: Acta endocrinol. 105: 521–527, 1984.
Madsen OD, Landin-Olsson M, Bille G, Sundkvist G, Lernmark Å, Dahlquist G, Ludvigson J: A two-colour immunofluorescence test with 1 monoclonal human proinsulin antibody improves the assay for islet cell antibodies: Diabetologia 29: 115–118, 1986.
Gorsuch AN, Spencer KM, Lister J, McNally JM, Dean BM, Bottazzo GF, Cudworth AG: The natural history of type 1 (insulin-dependent) diabetes mellitus: Evidence for a prolonged prediabetic period: Lancet ii: 1363–1365, 1981.
Srikanta S, Gimda O, Eisenbarth G, Soeldner JS: Islet cell antibodies and beta cell function in monozygotic triplets and twins initially discordant for type 1 diabetes mellitus: N. Engl. J. Med. 308: 322–325, 1983.
Marner B, Agner T, Binder C, Lernmark Å, Nerup J, Mandrup-Poulsen T, Walldorf S: Increased reduction in fasting C-peptide is associated with islet cell antibodies in Type 1 (insulin-dependent) diabetic patients: Diabetologia 28: 875–880, 1985.
Mandrup-Poulsen T, Nerup J, Stiller CR, Marner B, Bille G, Heinrichs D, Marstell R, Dupse J, Keown PA, Jenner MR, Rodger NW, Wolfe B, Graffenried BV, Binder C: Disappearance and reappearance of islet cell cytoplasmic antibodies in cyclosporin — treated insulin-dependent diabetics: Lancet i: 599–602, 1985.
Winkel van de M, Smets G, Gepts W, Pipeleers DG: Islet cell surface antibodies from insulin-dependent diabetics bind specifically to pancreatic B-cells: J. Clin. Invest. 70: 41–49, 1982.
Huen A, Haneda M, Freedman Z, Lernmark Å, Rubenstein AH: Quantitative determinations of islet cell surface antibodies using 125I-protein A: Diabetes 32: 460–465, 1983.
Dyrberg T, Poussier P, Nakhooda F, Marliss EB, Lernmark Å: Islet cell surface and lymphocyte antibodies often precede the spontaneous diabetes in the BB rat: Diabetologia 26: 159–165, 1984.
Pipeleers D, Winkel van de M, Dyrberg T, Lernmark Å: The spontaneously diabetic BB rats have age-dependent B cell specific surface antibodies at the time of onset: (Submitted for publication), 1986.
Martin DR, Logothetopoulos J: Complement-fixing islet cell antibodies in the spontaneously diabetic BB rat: Diabetes 33: 93–96, 1984.
Dobersen MJ, Scharff JE, Ginsberg-Fellner FBS, Notkins AL: Cytotoxic autoantibodies to beta cells in the serum of patients with insulin-dependent diabetes mellitus: N. Engl. J. Med. 303: 1493–1498, 1980.
Hartling SG, Lindgren F, Dahlquist G, Thalme B, Möller E, Efendic S, Persson B, Binder C: Proinsulin — a possible subclinical indicator for B-cell dysfunction: Diabetologie 29: 202 A, 1986.
Lernmark Å, Kanatsuna T, Rubenstein AH, Steiner DF: Detection and possible functional influence of antibodies directed against pancreatic islet cell surface: Adv. Exp. Med. Biol. 119: 157–163, 1979.
Like AA, Appel MC, Rossini AA: Autoantibodies in the BB/W rat: Diabetes 31: 313–318, 1982.
Elders M, MacLaren NK: Identification of profound peripheral T lymphocyte immunodeficiencies in the spontaneously diabetic BB rat: J. Immunol. 130: 1723–1731, 1983.
Contreas G, Lernmark Å, Mathiasen ER, Deckert T: Immune complexes in insulin-dependent diabetes: Biomed. Acta 44, 1: 129–132, 1985.
Boitard C, Debray-Sachs M, Pouplard A, Assan R, Hamburger J: Lymphocytes from diabetics suppress insulin release in vitro: Diabetologia 21: 41–46, 1981.
Sensi M, Pozzilli P, Gorsuch AN, Bottazzo GF, Cudworth AG: Increased killer cell activity in insulin-dependent (Type 1) diabetes mellitus: Diabetologia 20: 106–109, 1981.
Wilson RG, Anderson J, Shenton BK, White MD, Taylor RMR, Proud G: Natural killer cells in insulin-dependent diabetes mellitus: Br. Med. J. 293: 244, 1986.
MacKay P, Boulton A, Rabinovitch A: Lymphoid cells of BB/W diabetic rats are cytotoxic to islet beta cells in vitro: Diabetes 34: 706–709, 1985.
Koevary S, Rossini AA, Stollen W, Chick WL: Passive transfer of diabetes in the BB/W rat: Science 220: 727–728, 1983.
Handler ES, Mordes JP, Seals J, Koevary S, Like AA, Nakano K, Rossini AA: Diabetes in the Biobreeding/Worcester rat. Induction and acceleration by spleen cell-conditioned media: J. Clin. Invest. 76: 1692–1694, 1985.
Mordes JP, Handler ES, Like AA, Nakano K, Rossini AA: Irradiated lymphocytes do not adoptively transfer diabetes or prevent spontaneous disease in the BB/W rat: Metabolism 35: 552–554, 1986.
Feutren G, Assan R, Karsenty G, Du Rostu H, Sirmai J, Papoz L, Vialettes B, Vexiau P, Rodier M, Lallemand A, Bach J-F: Cyclosporin increases the rate and length of remissions in insulin-dependent diabetes of recent onset: Lancet ii: 119–123, 1986.
Jaworski MA, Honore L, Jewell LD, Metha JG, McGuire-Clark P, Schouls JJ, Yap WY: Cyclosporin prophylaxis induces long-term prevention of diabetes, and inhibits lymphocytic infiltration in multiple target tissues in the high-risk BB rat: Diabetes Research 3: 1–6, 1986.
Stiller CR, Laupacis A, Keown PA, Gardell C, Dupre J, Thibert P, Wall W: Cyclosporin: Action, pharmacokinetics and effect in the BB rat model: Metabolism 32 suppl. 1: 69–72, 1983.
Like AA, Kislauskis E, Williams RM, Rossini AA: Neonatal thymectomy prevents diabetes mellitus in the BB/W rat: Science 216: 644–646, 1982.
Naji A, Silvers WK, Bellgrau D, Anderson AO, Plotkin S, Barker CF: Prevention of diabetes in rats by bone marrow transplantation: Ann. Surg. 194: 328–338, 1981.
Brayman KL, Markmann J, Silvers WK, Barker CF, Naji A: Neonatal bone marrow transplantation and the prevention of diabetes in BB rats: Immunology of Diabetes, Edmonton, Canada: S39, 1986.
Rossini AA, Faustman D, Woda BA, Like AA, Szymanski I, Mordes J: Lymphocyte transfusions prevent diabetes in the Bio-Breeding/Worcester rat J. Clin. Invest. 74: 39–46, 1984.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Martinus Nijhoff Publishing, Boston
About this chapter
Cite this chapter
Markholst, H., Lernmark, Å. (1987). Autoimmunity in Diabetes. In: Becker, Y. (eds) Virus Infections and Diabetes Mellitus. Developments in Medical Virology, vol 2. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2085-2_6
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2085-2_6
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9236-4
Online ISBN: 978-1-4613-2085-2
eBook Packages: Springer Book Archive